StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$50.20M. The highest annual figure on record is -$50.20M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.20M–
FY2024Dec 31, 2024-$236.84M–
FY2023Dec 31, 2023-$312.19M–
FY2022Dec 31, 2022-$312.39M–
FY2021Dec 31, 2021-$228.17M–
FY2020Dec 31, 2020-$74.30M–

More Alvotech figures

See a number that looks wrong?